In addition, both of in vivo and in vitro experiments suggested that NEDD4L might advance the MAPK/ERK signaling pathway to weaken the proliferation of HCC cells via the induction of apoptosis (13). Here, NEDD4L is linked to hepatocellular carcinoma.